Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lilu Guo

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Communications Biology|November 30, 2024
Unravelling neuronal and glial differences in ceramide composition, synthesis, and sensitivity to toxicityJohn J McInnis, Disha Sood, Lilu Guo, et al.
Antioxidants & Redox Signaling|March 10, 2015
Isolevuglandin-type lipid aldehydes induce the inflammatory response of macrophages by modifying phosphatidylethanolamines and activating the receptor for advanced glycation endproductsLilu Guo, Zhongyi Chen, Venkataraman Amarnath, et al.
Elife|May 30, 2023
Osteonecrosis in Gaucher disease in the era of multiple therapies: Biomarker set for risk stratification from a tertiary referral centerMohsen Basiri, Mohammad E Ghaffari, Jiapeng Ruan, et al.
American Journal of Hematology|June 17, 2026
Cumulative Antigen Suppression Reduces Clonal Plasma Cell Evolution in Gaucher DiseaseNoor Ul Ain, Noffar Bar, Lilu Guo, et al.
American Journal of Cancer Research|February 9, 2026
TMEM121 suppresses cervical cancer cell proliferation and migration via interaction with the ERK pathwayHaochen Wang, Siting Xu, Sihui Li, et al.
The Journal of Biological Chemistry|May 8, 2026
A Comprehensive Discovery Platform for ELOVL1 Small Molecule Inhibitors Targeting Very Long Chain Fatty Acid Synthesis in AdrenoleukodystrophyStephanie Holley, Gary Asmussen, Becky Lam, et al.
The Journal of Clinical Investigation|June 25, 2014
Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesityZhongyi Chen, Lilu Guo, Yongqin Zhang, et al.
Cell Reports|May 12, 2021
RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosisMatija Zelic, Fabrizio Pontarelli, Lisa Woodworth, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 16, 2025
Blood phenylalanine lowering partially reverses white matter changes in a mouse model of phenylketonuriaRachna Manek, Weixiao Huang, Yinyin Huang, et al.
Elife|August 16, 2022
Neuroinflammation in neuronopathic Gaucher disease: Role of microglia and NK cells, biomarkers, and response to substrate reduction therapyChandra Sekhar Boddupalli, Shiny Nair, Glenn Belinsky, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Communications Biology|November 30, 2024
Unravelling neuronal and glial differences in ceramide composition, synthesis, and sensitivity to toxicityJohn J McInnis, Disha Sood, Lilu Guo, et al.
Antioxidants & Redox Signaling|March 10, 2015
Isolevuglandin-type lipid aldehydes induce the inflammatory response of macrophages by modifying phosphatidylethanolamines and activating the receptor for advanced glycation endproductsLilu Guo, Zhongyi Chen, Venkataraman Amarnath, et al.
Elife|May 30, 2023
Osteonecrosis in Gaucher disease in the era of multiple therapies: Biomarker set for risk stratification from a tertiary referral centerMohsen Basiri, Mohammad E Ghaffari, Jiapeng Ruan, et al.
American Journal of Hematology|June 17, 2026
Cumulative Antigen Suppression Reduces Clonal Plasma Cell Evolution in Gaucher DiseaseNoor Ul Ain, Noffar Bar, Lilu Guo, et al.
American Journal of Cancer Research|February 9, 2026
TMEM121 suppresses cervical cancer cell proliferation and migration via interaction with the ERK pathwayHaochen Wang, Siting Xu, Sihui Li, et al.
The Journal of Biological Chemistry|May 8, 2026
A Comprehensive Discovery Platform for ELOVL1 Small Molecule Inhibitors Targeting Very Long Chain Fatty Acid Synthesis in AdrenoleukodystrophyStephanie Holley, Gary Asmussen, Becky Lam, et al.
The Journal of Clinical Investigation|June 25, 2014
Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesityZhongyi Chen, Lilu Guo, Yongqin Zhang, et al.
Cell Reports|May 12, 2021
RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosisMatija Zelic, Fabrizio Pontarelli, Lisa Woodworth, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 16, 2025
Blood phenylalanine lowering partially reverses white matter changes in a mouse model of phenylketonuriaRachna Manek, Weixiao Huang, Yinyin Huang, et al.
Elife|August 16, 2022
Neuroinflammation in neuronopathic Gaucher disease: Role of microglia and NK cells, biomarkers, and response to substrate reduction therapyChandra Sekhar Boddupalli, Shiny Nair, Glenn Belinsky, et al.
Pageof 4